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RESUMO: Evidências clínicas e experimentais apontam para 
o papel das células do sistema imunológico e mediadores infla-
matórios no desenvolvimento de doenças em pacientes obesos. 
Nosso objetivo neste trabalho é explorar estudos experimentais 
que abordam a relação entre os diferentes tipos de reação in-
flamatória no tecido adiposo, particularmente a polarização de 
macrófagos e o desenvolvimento de complicações da obesidade. 
Além disso, temos a intenção de especular como traduzir esse 
conhecimento, obtido a partir de estudos experimentais, em 
tratamentos aplicáveis às doenças humanas. Para tanto, foi rea-
lizada busca no banco de dados PubMed, usando-se os termos 
“obesidade”, “macrófago” e “polarização”. Depois de aplicados 
os filtros “Idioma - Inglês” e “espécies - Animais”, chegamos a 
90 referências. Sessenta e duas dessas foram excluídas por serem 
revisões ou não estarem relacionados com o assunto principal. Os 
resultados em modelos experimentais de obesidade indicaram uma 
correlação significativa entre a polarização de macrófagos para 
uma resposta do tipo 1 (M1) no interior do tecido adiposo branco 
e o desenvolvimento de resistência à insulina, diabetes e outras 
complicações da obesidade. Vários artigos relatam estratégias 
de mudança para o fenótipo tipo 2 (M2), como uso de drogas ou 
mudanças de estilo de vida. Ainda é uma questão em aberto o 
modo como estas descobertas podem ser traduzidas para novos 
tratamentos em seres humanos , o que só poderá ser respondido 
por pesquisas bem elaboradas.
Descritores: Macrófagos; Obesidade; Tecido adiposo; Modelos 
animais. 
ABSTRACT: Clinical and experimental evidences pointed to the 
role of immune cells and inflammatory mediators on the develop-
ment of diseases in obese patients. Therefore, it is our objective 
to explore experimental studies that approach the relationship 
between the different types of inflammatory reaction inside the 
adipose tissue, particularly the macrophage polarization and the 
development of obesity complications. Further, we intend to 
speculate how to translate this knowledge, obtained from experi-
mental studies, to treatments applicable to the human diseases. 
PubMed database was sought using the terms “obesity”, “macro-
phage” and “polarization”. After applying the filters “Language 
- English” and “Species - Animals”, we arrived to 90 references. 
Sixty-two were excluded for being reviews or not related to the 
main subject. Results in experimental models of obesity pointed a 
relevant correlation between the macrophage polarization to a type 
1 response (M1) inside white adipose tissue and the development 
of insulin resistance, diabetes and other complications of obesity. 
Several articles report strategies to shift to a type 2 phenotype 
(M2), using drugs or lifestyle changes. How these findings could 
be translated to new human treatments is still an open question 
that only well designed researches could answer.
Keywords: Macrophages; Obesity; Adipose tissue; Models, 
animal.
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BACKGROUND
 
Obesity results from an imbalance between caloric intake and energy expenditure, 
leading to increased storages of fat inside adipocytes 
throughout the body1. This is clinically characterized by 
an increased Body Mass Index (BMI), defined as the ratio 
between weight (in kilograms) and the squared height (in 
meters). Individuals with a BMI higher than 30 kg/m² are 
considered obese, while the ones between 25 and 30 are 
classified as overweighed2.
Recent epidemiologic studies have reported that 
one third of the United States population is obese and this 
trend is expanding to developing countries3. Several causes 
have been proposed to account for this phenomenon, 
particularly the ones related to the comforts of modern 
life: gradual reduction of manpower in performing labor 
tasks and daily activities; enhanced offer of industrialized 
foods, usually rich in sugar and fat; increased income, 
allowing the families a higher degree of consumption3.
Obesity is widely recognized as a major 
contributing factor to the development of several 
diseases4. There is plenty of clinical and epidemiological 
evidence of this relationship in diseases such as type 2 
diabetes5, dyslipidemias and cardiovascular syndromes6. 
In other situations, like cancer7 and dementia8, for 
example, evidences are more scarce and questionable. As 
a consequence, vital resources have been allocated to treat 
these maladies, that, ultimately, have obesity as one of the 
main causes for their development3.
In recent years, much interest has been directed 
to the relationship between obesity and systemic 
inflammation9. It has been proposed that some of the 
aforementioned diseases appear in obese patients with 
high levels of inflammatory circulating markers10. 
Moreover, attention has been caught by patients with 
high BMI but no other comorbidity. The mechanisms that 
cause this “healthy obesity” are still being discussed11.
Therefore, it is our objective to explore experimental 
studies that approach the relationship between the 
different types of inflammatory reaction inside the adipose 
tissue, particularly the macrophage polarization and the 
development of obesity complications. Further, we intend 
to speculate how to translate this knowledge, obtained 
from experimental studies, to treatments applicable to the 
human diseases.
METHODOLOGY
In order to search for the proposed theme, one 
database was used (PubMed), accessed on December 
15th, 2015.
The key terms were “obesity”, “macrophage” 
and “polarization”. Using these terms, 132 articles were 
retrieved (Figure 1).
Additionally, two filters were used: “Language - 
English” and “Species: Animals”. Two articles were ruled 
out for not being written in English. Another forty articles 
were excluded by the filter Species.
Therefore, we obtained 90 articles. Initially, 
reading only the titles and abstracts, additional 62 articles 
were excluded because were not related to the main 
objective of our review, or for being reviews themselves.
Although reviews were found with the searched 
keywords, many specifically address only macrophage 
polarization mechanisms, the physiology behind 
macrophage polarization or compounds that act on 
inflammation and complications of obesity. The few 
reviews that associate macrophage polarization with 
obesity are specific to a modulation mechanism of 
polarization, such as drugs or lifestyle habits.
Our review has a comprehensive and translational 
approach. We intend to describe, compare and evaluate 
macrophage polarization mechanisms while linking them 
to obesity. We focus on describing changes in obesity 
and its comorbidities framework caused by the numerous 
modulation possibilities of macrophage polarization.
We arrived at 28 articles, which were read and 
resumed by the authors. In further discussions, these 
articles were divided in four topics:
- the role of inflammation on the genesis of clinical 
complications of obesity;
- the role of macrophage polarization on this 
phenomenon;
- the signaling pathways and mediators responsible 
for polarizing macrophages in obesity;
- how to shift macrophage polarization inside the 
adipose tissue.
Therefore, this review is structured in five main 
topics, beginning with a brief analysis of the importance 
of obesity as epidemiological factor in modern society, 
followed by a short discussion on pathophysiology, 
approaching in more detail the connection between 
inflammation and obesity and the onset of diseases. 
Following, macrophages polarization is conceptualized 
and is made an exposition on the researching involving 
some of the major known forms of changing the balance 
between the M1 and M2 types, including by intracellular 
signaling pathways, with emphasis on diet, exercise and 
pharmacological drugs. At the end, based on the revised 
texts, it is carried the study of translation, assessing which 
mechanisms could be adopted for the control of obesity 
and its harmful effects to humans.
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Pubmed Search  




 “polarization”.  
132 articles 
130 articles 
90 articles  
28 articles  
Read and discussed 
Review in four topics 
Excluded: 2 
Filter: Language - English 
Excluded: 40 
Filter: Species - Animals 
Excluded: 62 
After reading abstracts 
Not related to main issue or reviews 
Figure 1. Flow of information through the different phases of this review
RESULTS
 
In order to better understand the studies aimed 
to manipulate the inflammatory response inside the 
white adipose tissue, we initially describe our current 
knowledge about the role of inflammation on the obesity 
complications.
Obesity and inflammation
During human evolutionary pathway, body fat 
storages meant the difference between life or death in 
times of starvation or pathogen challenge12. However, 
over the last century, the major threat of energy deficit 
to living organisms has been replaced by overnutrition 
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of humans in the developed world. As a consequence, 
a chronic imbalance between enhanced calories intake 
and diminished expenditure led to increased number of 
individuals with pathological expansion adipose tissue3.
In the last decades, it has been demonstrated 
that these fat deposits are also the source of a chronic 
low-grade inflammation, which mechanisms are still 
being discovered9. Several processes were proposed 
to explain inflammation inside the adipose tissue. It is 
known, for example, that adipocytes may, by themselves, 
release inflammatory mediators like cytokines 13 and 
chemokines14. Also, hypertrophic adipocytes, overloaded 
with fat, fail to efficiently store the excess of energy, 
releasing intracellular antigens that may act also as 
immune cells activators15 (Figure 2).
These processes are part of a self-perpetuating 
inflammatory reaction that is detected through increased 
circulating markers and leads to adipose tissue 
dysfunction, dyslipidemia, and insulin resistance9.
Clinical and experimental evidences pointed that 
progression of clinical diseases related to obesity has 
been strongly linked to chronic inflammation of white 
adipose tissue and the resultant increased circulating 
concentrations of inflammatory markers16.
Overnutrition leads to increased fat deposits and inflammatory process inside the white adipose tissues. Several processes 
were proposed to explain this phenomenon: inflammatory mediators secretion by adipocytes themselves, release of intra-
cellular antigens by overloaded adipocytes, recruiting immune cells, among others. The main result is a self-perpetuating 
inflammatory reaction that is detected through increased circulating markers and leads to adipose tissue dysfunction, 
dyslipidemia, and insulin resistance
Figure 2. Obesity and inflammation7
Obesity and macrophage polarization
At the center of this inflammatory process inside 
the adipose tissues are the macrophages. There is plenty 
of evidence that these cells may be responsible for shifting 
the adipose tissue inflammation between the Th1 and Th2 
responses. Th1 and Th2 helper cells both result from 
stimulation of naive T CD4 + cells, respectively by IL-12 
and IL-4. They differ primarily because the Th1 produce 
cytokines, such as interferon gamma (INF-γ), IL-2 and 
Tumor Necrosis Factor alpha (TNF-α), mainly related to 
defense against intracellular infectious agents, whereas 
Th2 secrete interleukins mainly related to IgE production 
and the activation of eosinophils. Th1 responses are mostly 
proinflammatory, and Th2 counteracts them, reducing 
inflammation. The consequences of this shifting are 
observed in the clinical set as a majority of obese patients 
struggling with multiple metabolic and cardiovascular 
diseases and, on the other side, those who could be called 
the “healthy obeses”17,18.
The first evidence for a pathophysiological link 
between obesity, macrophages infiltration and insulin 
resistance was provided a decade ago, when it was shown 
that these cells accumulate inside the adipose tissue 
and are the principal source of inflammatory mediators, 
including TNF-a, expressed by this metabolic tissue19.
Further, it was demonstrated that adipose tissue 
macrophages (ATM) differ not only in number, but also 
in inflammatory phenotype and tissue localization. In a 
series of seminal works, it was shown that mice fed with 
high-fat diets present a larger population of macrophages 
F4 / 80 (+) CD11c (+), that are not found in mice with 
normal diet. Those macrophages express TNF-alpha and 
iNOS-coding genes, known to be pro-inflammatory20. On 
the other side, ATMs of lean mice, express many genes 
related to M2 macrophages, such as Ym1, arginase 1, 
and IL10. Besides being an inflammation suppressor, the 
cytokine IL-10 is associated with stimulation of the influx 
of glucose by adipocytes and, so, indicates a contribution 
from those kind to the reduction of insulin resistance17,20,21.
 
Inflammatory mediators responsible for M1/M2 
shifting in adipose tissue
The mechanisms responsible for macrophage to 
develop an M1 or M2 phenotype inside the macrophages 
are still not completely understood, however, the cellular 
environment and the adipocyte metabolism seem to exert 
major effects (Figure 2).  
The interaction of macrophages and lymphocytes 
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with adipocytes is associated with inflammation of the 
adipose tissue found in obese animals. The CD40-CD40L 
system is costimulatory, being important in inflammatory 
reactions and activation of T cells22,23. Recently, it was 
shown that CD40L can promote inflammation of adipose 
tissue in vivo. To clarify how is the interaction of CD40L 
with adipocytes and chemokines and its relationship 
with inflammation in adipose tissue, cells of this kind 
were stimulated with CD40L, TNF and palmitate, being 
observed their migration, and that there was no change 
in the adhesion of adipocytes to T cells. Stimulation 
with CD40L showed an increase in expression of CD40 
and the chemokines MCP-1, CCL4 and CCL5. TNF 
also stimulated CD40, however palmitate had no effect. 
Chemokines attracted monocytes and macrophages to 
the adipose tissue. The presence of the CD40L has also 
resulted in high migration of lymphocytes and increased 
expression of proinflammatory genes, i.e., genes capable 
of stimulating the permanence of M1 macrophages 
polarization24.
Although it does not prevent the accumulation of 
macrophages, the toll-like receptor 4 deficiency attenuates 
inflammation in obesity. To demonstrate the effects of 
TLR4 deficiency in inflammation and insulin resistance, 
typical of that condition, and determine whether this 
deficiency promotes the polarization of macrophages in 
adipose tissue, mice were fed with three different diets: 
low-fat, rich in saturated or rich in monounsaturated fats, 
and, in a later step, marrow transplant was performed to 
assess the influence of TLR4 signaling in hematopoietic 
cells. It was confirmed that global and hematopoietic 
deficiency of TLR4 signaling produced changes in the 
phenotype of macrophages: it inclines them to M2, the 
anti-inflammatory polarization. The deficiency also 
reduces body fat and weight gain in small proportion, 
thought capable of significant effect on decreasing hepatic 
steatosis induced by a diet rich in lipids. There was not, 
however, influence either in insulin resistance or glucose 
homeostasis. Overexpression of ATF3, a TLR4 signaling 
repressor, caused a reduction in the polarization M1 
after 4 weeks of feeding with high-fat diet, suggesting, 
again, attenuation of the inflammatory response via TLR4 
silencing25.
The interplay between pro- and anti-inflammatory 
mediators in the ATMs is highly complex and, sometimes 
surprising. For example, one of the most important systemic 
cytokine, IL-6, seems to play a paradoxical role in this 
polarization phenomenon. To understand the role of IL-6 
signaling in macrophages in obesity, a study conditionally 
inactivated the Ii6ragene in myeloid cells in mice. They 
generated mice heterozygous for the LysM-Cre transgene, 
which is specifically expressed in myeloid lineage cells, 
and homozygous for the Il6ra-loxP-flanked allele (Il6rafl/
fl, LysM-CreTg/wt; will be called Il6raΔmyel throughout this 
review). Mice lacking a functional receptor for IL-6 had 
higher systemic inflammation and developed exaggerated 
deterioration of glucose homeostasis when in a state of 
diet-induced obesity, because of insulin resistance. The 
tissues affected by insulin showed increased inflammation 
and changes in the polarization of macrophages. IL-6 
signaling promotes IL-4 receptor expression and increased 
autonomic response to IL-4 in macrophages, but Il6raΔmyel 
were resistant to alternative polarization mediated by 
IL-4, and had greater susceptibility to endotoxemia 
induced by LPS. These results suggest that signaling by 
IL-6 is an important factor in the alternative activation 
of macrophages, but also plays an important homeostatic 
role in limiting the inflammatory state26.
Lipid-induced toxicity, related to the distribution 
of lipids between the ATMs and adipocytes, is another 
mechanism that may account for the state characteristic 
of obesity, involving inflammation and insulin resistance. 
It was observed that the early stages of adipocyte 
proliferation are most related to the M2 macrophage 
polarization and the growing accumulation of lipids in 
adipose tissue induces a polarization conversion to M1 
type27.
The intracellular signaling pathways activated in 
macrophages also seem to determine the fate of these cells. 
When the chemokine MCP1 is overexpressed, phenotype 
M1 predominates, the same occurring with disruption of 
signaling by the nuclear receptors PPAR-γ. Both genetic 
manipulations induce a pro-inflammatory status in the 
adipose tissue, leading to increased insulin resistance in 
mice28. Interestingly, PPAR-γ is known to be necessary to 
polarize macrophages to a M2 phenotype.
Similar results were obtained when another 
chemokine is stimulated. The C-C chemokine receptor 
5 (CCR5) is crucial in the migration of macrophages 
to adipose tissue. In obese animals, caused by either by 
genetic manipulation or food ingestion, it was shown that 
CCR5, and their ligands are overexpressed. The loss of 
CCR5 causes not only reduction in macrophages quantity 
in adipose tissue, but also prevents the M1 polarization. In 
addition, CCR5 knockout mice have shown to be immune 
to liver steatosis, diabetes induced by high-fat diet and 
insulin resistance29.
Even signaling pathways not directly related 
to inflammation control may affect ATM function. 
RBP4, a retinol carrier, is found in high concentration 
in insulin resistance states, and this resistance, along to 
being one of the main causes of diabetes, is associated 
with inflammation of the adipose tissue in obesity. The 
increased RBP-4 causes inflammation in adipose tissue 
through the activation of innate immunity, from which 
derives an adaptive response. By enabling connections 
between the innate and adaptive immune systems, 
activating antigen-presenting cells in the adipose tissue to 
induce polarization of CD4 Th1 cells, RBP-4 contributes 
to insulin resistance and adipose tissue inflammation30.
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Pathways known for its ability of controlling 
metabolism are also able to influence the macrophage 
polarization. One example is the PPAR, as described 
above, and other is its counterpart, the C/EBPα 
transcription factor, that is highly expressed in 
macrophages. When establishing its role in regulating the 
function of macrophages and energy homeostasis, it was 
found that macrophages from C/EBPα knockout mice 
(MαKO) presented impaired polarization response after 
induction by cytokines, suggesting that C/EBPα controls 
both polarizations. While in MαKO fed normal diet it 
was observed deterioration in mitochondrial respiration 
rate and the signals for fatty acid oxidation, findings 
consistent with lower exercise capacity, in MαKO high-
fat fed mice the levels of inflammatory cytokines were 
reduced. These results mean that the C/EBPα is required 
for the activation of macrophages, and this, in turn, as 
well as its relative insulin influence, has an important role 
in the maintenance of skeletal muscle insulin sensitivity 
and normal metabolism31
The few studies listed above exemplify the 
complexity and broadness of the signaling pathways 
controlling the macrophage polarization inside the 
adipose tissue. Although some of the mechanisms are not 
completely understood, there is a consensus, however, 
that macrophages polarized to an M1 response become 
the individual more prone to obesity complications, 
like insulin resistance (and diabetes) and cardiovascular 
diseases. On the other side, macrophages with an M2 
phenotype seem to protect individuals to these diseases.
Therefore, finding ways to manage the ATMs 
phenotype may be an interesting method to prevent 
obesity complications.
How to shift macrophages inside the adipose tissue 
from M1 to M2
Weight loss and, particularly, maintenance is a 
difficult task for doctors and their patients32. A combination 
of low calories intake and exercise is the only method 
available so far, regardless of the diet prescribed, and 
its long term adherence is always cause of concern33. 
Therefore, finding treatments that can reduce obesity 
complications is an urgent goal for researchers, in order to 
diminish the health burden of these diseases.
As described above, there is a direct relationship 
between obesity complications and the inflammatory 
response inside the adipose tissue. Moreover, these 
complications are more common when adipose tissue 
macrophages are polarized to an M1 response and are less 
prevalent when these ATMs express an M2 phenotype.
There is no consensus whether macrophages, 
once committed to a particular phenotype, can change 
to another (Figure 3). Nevertheless, in a recent study, 
it was reported that bone marrow derived macrophages 
(BMDM) from high fat-fed mice, when placed in culture, 
retain their ability to secrete cytokines characteristic of a 
pro-inflammatory (M1) profile. Interestingly, incubation ex 
vivo with palmitoleate, an omega-7 monounsaturated fatty 
acid, reverses this trend. When the culture was performed 
with BMDM from low fat-fed mice, exposure to palmitate, 
a saturated fatty acid, triggered a marked increased 
expression of proinflammatory genes associated with M1 
polarization34. Although these results were obtained ex 
vivo, under controlled circumstances (cell culture), they are 
important since they demonstrate the plasticity of BMDM 
polarization in response to saturated and unsaturated fatty 
acids. Also, these findings point to the role of diets as 
therapeutic tools to reverse obesity-linked inflammation 
in metabolically relevant tissues.
LPS: lipopolisaccharide; IL: interleukin; TNF: 
tumor necrosis factor; IFN: interferon; NO: ni-
tric oxide; iNOS: nitric oxide synthase 2; ROS: 
reactive oxygen species; ILiRa: interleukin 1 
receptor antagonist. 
In experimental models, macrophages with a 
phenotype M1 are found in obese animals and 
correlate with the development of insulin resis-
tance and other metabolic diseases, while M2 
macrophages are encountered in lean subjects. 
This polarization process is not completely 
understood. In the upper panel we can observe 
some of the stimuli that shifts macrophage to a 
M1 phenotype, the intracellular mediators and, 
on the right, some of the characteristics of these 
type of cells. On the lower panels, the M2 phe-
notype. Usually there are various populations of 
macrophages inside adipose tissues, with plastic-
ity across the entire spectrum of activation states 
encompassed by the M1 and M2 nomenclature.
Figure 3. Macrophage polarizarion
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The role of fatty acids in ATM polarization was 
also studied in vivo. Mice fed a high fat diet showed 
increased F4/80 and CD11b double-positive macrophage 
staining and elevated IL-6 and MCP-1 levels in the 
adipose tissue. When the same diet was supplemented 
with docosahexaenoic acid (DHA), a typical long-chain 
polyunsaturated fatty acid (PUFA) of the ω-3 series, no 
difference was observed in the total number of macrophages 
but significantly reduced the percentage of high CD11b/
high F4/80-expressing cells in parallel with the emergence 
of low-expressing CD11b/F4/80 macrophages in the 
adipose tissue, suggesting an increased number of M2 cells, 
compared to animals that did not receive DHA. It seems 
that resolvin D1, an anti-inflammatory and proresolving 
mediator biosynthesized from DHA, is the main culprit 
for this phenomenon35. Nonetheless, these results were 
not confirmed for other PUFAs. Mice were fed a high fat 
containing different omega-6:omega-3 ratios, manipulated 
through the α-linolenic and linoleic acid contents. This 
study concludes that the omega-6:omega-3 ratio reduction 
with only alpha-linolenic acid (ALA), is not an effective 
therapy in reducing obesity or retarding the development 
of type 2 diabetes mellitus, and all high fat diets lead to 
similar levels of inflammatory markers, although 1:1 ratio 
reduces the infiltration of macrophages. It is likely that the 
use of eicosapentaenoic acid (EPA) and docosahexaenoic 
acid (DHA) for the same purpose are more useful because 
these acids, besides being potent activators of GPR 120 
(a G-protein-coupled receptor), can be stored directly in 
phospholipids, and, hence, do not compete for enzymes to 
be incorporated into the cell membrane36.
Other strategies to manipulate the macrophage 
phenotype inside the adipose tissue involve tempering with 
the immune response. Some inflammatory mediators that 
may influence the Th1/Th2 response were tested in vitro and 
in experimental models. Obese mice treated with interferon 
tau (IFNT), a member of the type I interferon family 
with low cellular toxicity even at high doses, developed 
enhanced insulin sensitivity compared to control mice. This 
phenomenon was accompanied by a significant decrease 
in the levels of proinflammatory cytokines and increased 
presence of M2 macrophages in adipose tissue37.
Another target is the membrane receptor cytotoxic 
T-lymphocyte-associated protein 4 (CTLA-4) that functions 
as an immune checkpoint, downregulating immune 
responses38. When activated by an immune complex 
(CTLA-4Ig) in obese mice, CTLA-4Ig prevented insulin 
resistance by changing gene expression to M2 polarization 
in ATM, elevating arginase expression and decreasing the 
secretion of cytokines and pro-inflammatory chemokines39.
Interleukin-33 and its receptor ST2 are found in 
adipose tissue and it seems to reduce inflammation in obese 
mice. In vitro, IL-33 stimulates the production of Th2 
cytokines. In vivo, recombinant IL-33 induces, preferably, a 
M2 polarization, and has several other effects, particularly 
reduction of adipose tissue and improved insulin tolerance. 
These findings may be related to the ability of IL-33 of 
triggers accumulation of M2 macrophages in adipose 
tissue. Mice that lack the ST2 receiver, when subjected to 
high-fat diet have a poorer response, with greater weight 
and fat gain, reduced insulin secretion and worse regulation 
of glycaemia, implying that IL-33 may actually have a 
significant role in chronic inflammation related to obesity40.
Promising also, are the strategies that use helminth 
proteins to stimulate a Th2 response.  Helminths are the 
largest natural inductor of type 2 immune responses, and 
there are reports of improvement in glucose tolerance in 
obese mice after infection with nematodes. It was observed 
that inducing infection in mice fed with high-fat diet 
provokes significant reduction in body weight gain, fat mass 
and size of adipocytes, with lower insulin resistance and 
glucose intolerance. Peripheral glucose uptake and white 
adipose tissue sensitivity to insulin were also improved. 
The same result was obtained with injection of antigens 
obtained from eggs of S. mansoni, which conducts to 
the conclusion that chronic infections with helminths or 
contact with molecules derived from them have protective 
effect against metabolic disorders, obtained through Th2 
response, eosinophilia and M2 polarization in white adipose 
tissue41.
Some drugs acting on other pathways, not primarily 
related to the immune response, have also been tested in 
obese animals. Telmisartan, an angiotensin receptor blocker 
II type 1, acts to decrease the number of M1 macrophages 
in visceral adipose tissue, improving insulin sensitivity 
and modulating the polarization of macrophages to M2 
state in mice with high-fat diets42. Rosiglitazone, a PPAR-
gamma activator, was able to increase the M2 population 
whereas reducing the occurrence of damages caused by M1 
polarization. Rosiglitazone induces a more homogeneous 
distribution of lipids between adipocytes, decreasing the 
M1 response and improving insulin sensitivity in obese 
mice27.
Finally, a few studies also investigated the effect 
of exercise on adipose tissues macrophage infiltration and 
function. Obese mice fed a high fat diet submitted to chronic 
aerobic exercise for 16 weeks did not present differences in 
body or adipose tissue mass, compared to their sedentary 
control. However, exercise training markedly impaired 
TNF-alpha, F4/80, ICAM-1 and CD11c expression in 
adipose tissue, while increasing CD163 expression, a 
marker of M2 polarization43. More recently it was reported 
that even acute exercise may interfere with macrophage 
polarization. Obese rats submitted to forced swimming 
(two 3-hour of moderate exercise bouts, separated by 
one 45-minute rest period) presented an improved insulin 
signaling in white adipose tissue fractions, as detected by 
enhanced phosphorylation of tyrosine IRbeta and IRS-
1-induced insulin release. Moreover, it was observed a 
phenotypic switch from M1- to M2-macrophages, as 
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indicated by a marked increase in macrophage galactose-
type C-type lectin 1-positive cells and a reduction in 
circulating levels of lipopolysaccharide, and toll-like 
receptor 4 activity along with TNF-alpha, IL-1-beta and 
MCP-1 mRNA levels in white adipose tissue fractions. 
Exercised rats also had increased the levels of IL-10, anti-
inflammatory cytokine characteristically associated with 
the stimulation of glucose uptake in adipocytes, setting 
another possible mechanism by which the polarization of 
macrophages may reduce inflammation44.
Another recent trend in the scientific literature about 
obesity is the relationship between intestinal flora and 
obesity complications, particularly insulin resistance45. It 
seems to be a very relevant issue, however, it was out of our 
scope in this review and it needs a more focused approach 
than the one we could offer in the available space here.
CONCLUSION
How to translate this knowledge to humans?
 
In humans, progression of insulin resistance, 
diabetes and other metabolic diseases in obese individuals 
has been also strongly linked to obesity-associated chronic 
inflammation of white adipose tissue and the resultant 
increased circulating concentrations of inflammatory 
markers46.
Early reports showed a marked decrease in 
macrophages infiltrating white adipose tissue after a 
significant weight loss. This finding was related to a 
diminished inflammatory response, measured by circulating 
markers, and improvement in peripheric insulin resistance47. 
Changes in the phenotype of the macrophages, however, 
were not reported.
Moreover, in adipose tissues obtained from 
women submitted to bariatric surgery, there was a direct 
relationship between the presence of macrophages with 
a M1 phenotype (expressing more CD11c and CD206 
and secreting more interleukins 1beta, 6, 8 and TNF-alfa) 
and insulin resistance48. In addition, sustained weight 
loss results in reduced total numbers of adipose tissue 
macrophages, which is accompanied by a decrease in pro-
inflammatory profiles of obese individuals47.
Nonetheless, to postulate a direct view of these 
findings may lead to an oversimplification. Usually there are 
various populations of macrophages inside adipose tissues, 
with plasticity across the entire spectrum of activation states 
encompassed by the M1 and M2 nomenclature21.
As could be seen throughout this review, polarization 
of macrophages inside the white adipose tissue is at 
the center of the pathogenesis of the diseases related 
to obesity. Above we also described several signaling 
pathways and inflammatory mediators that are involved 
in this phenomenon in animal models (Figure 4). More 
importantly, however, is the fact that these experimental 
studies provide a series of possible ways to change 
macrophages phenotypes, from changes in lifestyle to 
potential new drugs derived from parasites.
How these findings could be translated to new 
human treatments is still an open question that only well 
designed researches could answer.
There is no consensus whether macrophages, once committed to a particular phenotype, can change to another. However, several studies described 
in this review show that some drugs or lifestyle changes (diet and exercise) may shift the balance of this polarization, increasing the number of 
M2 macrophages inside white adipose tissue.
Figure 4. Factors affecting macrophage polarization in adipose tissue
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